Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Adenosine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 known ✓ | P30542 | 3/20 | 0.89 |
| ▸ | ADORA3 known ✓ | P0DMS8 | 3/20 | 0.89 |
| ▸ | ADORA2A known ✓ | P29274 | 1/20 | 0.89 |
| ▸ | ADORA2B known ✓ | P29275 | 1/20 | 0.89 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.89 |
| ▸ | DPP4 | P27487 | 1/20 | 0.89 |
| ▸ | MEN1 | O00255 | 1/20 | 0.89 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.89 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.89 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.89 |
| ▸ | GAPDH | P04406 | 1/20 | 0.89 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.89 |
| ▸ | STAT6 | P42226 | 1/20 | 0.89 |
| ▸ | PI4KA | P42356 | 1/20 | 0.89 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.89 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.89 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.89 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.89 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.89 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.89 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adenosine SCHEMBL6242700 | 1.00 | ADORA1 (0.89) | ADORA1SMN1; SMN2ADORA3DPP4MEN1 | |
| Adenosine SCHEMBL9171507 | 1.00 | ADORA1 (0.89) | ADORA1SMN1; SMN2ADORA3DPP4MEN1 | |
| Adenosine SCHEMBL3046213 | 1.00 | ADORA1 (0.89) | ADORA1SMN1; SMN2ADORA3DPP4MEN1 | |
| Adenosine SCHEMBL459769 | 1.00 | ADORA1 (0.89) | ADORA1SMN1; SMN2ADORA3DPP4MEN1 | |
| Adenosine SCHEMBL3031964 | 1.00 | ADORA1 (0.89) | ADORA1SMN1; SMN2ADORA3DPP4MEN1 | |
| Adenosine SCHEMBL1746637 | 1.00 | ADORA1 (0.89) | ADORA1SMN1; SMN2ADORA3DPP4MEN1 | |
| Adenosine SCHEMBL50788 | 1.00 | ADORA1 (0.89) | ADORA1SMN1; SMN2ADORA3DPP4MEN1 | |
| Adenosine SCHEMBL1744578 | 1.00 | ADORA1 (0.89) | ADORA1SMN1; SMN2ADORA3DPP4MEN1 | |
| Vidarabine SCHEMBL7103173 | 1.00 | ADORA1 (0.89) | ADORA1SMN1; SMN2ADORA3DPP4MEN1 | |
| Adenosine SCHEMBL9147194 | 1.00 | ADORA1 (0.89) | ADORA1SMN1; SMN2ADORA3DPP4MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 775 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4605523-A1 | OLIGONUCLEOTIDES AND METHODS FOR CAPTURING SINGLE-STRANDED TEMPLATES AND/OR TEMPLATES WITH 3' OVERHANGS | Foundation Medicine, Inc. (US) | 2025-08-27 | — | — | EP | claimed |
| WO-2024137316-A1 | OLIGONUCLEOTIDES AND METHODS FOR CAPTURING SINGLE-STRANDED TEMPLATES AND/OR TEMPLATES WITH 3' OVERHANGS | FOUNDATION MEDICINE, INC. (US) | 2024-06-27 | — | — | WO | claimed |
| US-11964149-B2 | Facial beautifying and care apparatus | BIBOTING INTERNATIONAL CO., LTD. (TW) | 2024-04-23 | — | — | US | claimed |
| US-20230225928-A1 | FACIAL BEAUTIFYING AND CARE APPARATUS | LIU PO CHANG (TW) | 2023-07-20 | — | — | US | claimed |
| EP-4153322-A1 | COUPLED TERPENE CONJUGATE | Laboratoires Eriger (FR) | 2023-03-29 | — | — | EP | claimed |
| WO-2022155751-A1 | PRENYLATED PSILOCYBIN DERIVATIVES AND METHODS OF USING | MAGICMED INDUSTRIES INC. (CA) | 2022-07-28 | — | — | WO | claimed |
| US-20220032050-A1 | FACIAL BEAUTIFYING AND CARE APPARATUS | LIU, PO-CHANG (TW) | 2022-02-03 | — | — | US | claimed |
| CN-108753808-A | A kind of recombinant expression carrier, recombinant expression host and its method for synthesizing adenosine triphosphoric acid | 浙江海正药业股份有限公司 | 2018-11-06 | — | — | CN | claimed |
| US-9193990-B2 | Bioluminescent metal ion assay | Thompson, Richard B. (US) | 2015-11-24 | — | — | US | claimed |
| US-20140273038-A1 | BIOLUMINESCENT METAL ION ASSAY | Thompson, Richard B. (US) | 2014-09-18 | — | — | US | claimed |
| US-20050009847-A1 | Compounds and methods for increasing neurogenesis | NEURONOVA AB (COMPANY REGISTRATION NO. 556703-0118) (SE) | 2005-01-13 | — | — | US | claimed |
| WO-2004045592-A2 | COMPOUNDS AND METHODS FOR INCREASING NEUROGENESIS | NEURONOVA AB (SE) | 2004-06-03 | — | — | WO | claimed |
| CN-1382699-A | Polypeptide-nuclear triphosphoddenosine bindin-30.47 and polynucleotide for coding it | BIOWINDOW GENE DEV INC (CN) | 2002-12-04 | — | — | CN | claimed |
| EP-0344807-B1 | Method for evaluating the permeability of a thin membrane | HAMAMATSU PHOTONICS KK (JP) | 1997-09-03 | — | — | EP | claimed |
| US-5059526-A | Storage stability, accuracy | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1991-10-22 | — | — | US | claimed |
| EP-0344807-A2 | Method for evaluating the permeability of a thin membrane | HAMAMATSU PHOTONICS K.K. (JP) | 1989-12-06 | — | — | EP | claimed |
| US-4833075-A | Immobilized luciferase for the quantitative determination of ATP | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 1989-05-23 | — | — | US | claimed |
| US-4698387-A | Allosteric conjugates of hemoglobin and use as blood substitutes | INTERMEDICAT GMBH (CH) | 1987-10-06 | — | — | US | claimed |
| EP-0145373-A2 | Purification of cancer-associated protein and preparation of antibody thereto | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1985-06-19 | — | — | EP | claimed |
| WO-1985002467-A1 | PURIFICATION OF CANCER-ASSOCIATED PROTEIN AND PREPARATION OF ANTIBODY THERETO | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1985-06-06 | — | — | WO | claimed |